Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Lifestyle modification is recommended in women with polycystic ovary syndrome (PCOS) prior to conception but there are few randomized trials to support its implementation or benefit. OBJECTIVE: This study aimed to determine the relative efficacy of preconception intervention on reproductive and metabolic abnormalities in overweight/obese women with PCOS. DESIGN, SETTING, AND PARTICIPANTS: This was a randomized controlled trial of preconception and infertility treatment at Academic Health Centers in women with infertility due to PCOS, age 18-40 y and body mass index 27-42 kg/m(2). INTERVENTION: Women were randomly assigned to receive either 16 weeks of 1) continuous oral contraceptive pills (OCPs) (ethinyl estradiol 20 mcg/1 mg norethindrone acetate) ("OCP"); 2) lifestyle modification consisting of caloric restriction with meal replacements, weight loss medication (either sibutramine, or orlistat), and increased physical activity to promote a 7% weight loss ("Lifestyle"); or 3) combined treatment with both OCP and lifestyle modification ("Combined"). After preconception intervention, women underwent standardized ovulation induction with clomiphene citrate and timed intercourse for four cycles. Pregnancies were followed with trimester visits until delivery. MAIN OUTCOME MEASURES: Weight, ovulation, and live birth were measured. RESULTS: We consented 216 and randomly assigned 149 women (Lifestyle: n = 50; OCP: n = 49; Combined: n = 50). We achieved significant weight loss with both Lifestyle (mean weight loss, -6.2%; 95% confidence interval (CI), -7.4--5.0; and Combined (mean weight loss, -6.4%; 95% CI, -7.6--5.2) compared with baseline and OCP (both P < .001). There was a significant increase in the prevalence of metabolic syndrome at the end of preconception treatment compared with baseline within OCP (odds ratio [OR, 2.47; 95% CI, 1.42-4.27) whereas no change in metabolic syndrome was detected in the Lifestyle (OR, 1.18; 95% CI, 0.63-2.19) or Combined (OR, 0.72; 95% CI, 0.44-1.17) groups. Cumulative ovulation rates were superior after weight loss: OCP, 46%; Lifestyle, 60%; and Combined, 67% (P < .05). Live birth rates were OCP, 12%; Lifestyle, 26%; and Combined, 24% (P = .13). CONCLUSIONS: A preconception weight loss intervention eliminates the adverse metabolic oral contraceptive effects and, compared with oral contraceptive pretreatment, leads to higher ovulation rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Weight reduction is the most important first-line treatment in restoring ovulation in women with PCOS and obesity (Hoeger et al., 2004;Legro et al., 2015).”
From Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention (2021) · cites this paper as Legro et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“Previous lifestyle intervention studies in women with PCOS also demonstrated improvements in menstrual cycle length and ovulation rates (Thomson et al., 2008;Moran andTeede, 2009, Legro et al., 2015;Oberg et al., 2019).”
From Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention (2021) · cites this paper as Legro et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
World Health Organization reference values for human semen characteristics*‡
Cooper, T. G., Noonan, E., von Eckardstein, S., Auger, J., Baker, H. W. G., Behre, H. M., Haugen, T. B., Kruger, T., Wang, C., Mbizvo, M. T., et al. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp048 · Cited by 2,827
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Self-citationMaternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London
Sebire, N., Jolly, M., Harris, J., Wadsworth, J., Joffe, M., Beard, R., Regan, L., & Robinson, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801670 · Cited by 1,743
A Prospective Study of Obesity and Risk of Coronary Heart Disease in Women
Manson, J. E., Colditz, G. A., Stampfer, M. J., Willett, W. C., Rosner, B., Monson, R. R., Speizer, F. E., & Hennekens, C. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221303 · Cited by 1,408
Cited by
Items 101–200 of 242
Nutritional support and dietary interventions for women with polycystic ovary syndrome
Papavasiliou, K., & Papakonstantinou, E. (2017) · Nutrition and Dietary Supplements · doi:10.2147/nds.s119738 · Cited by 29
“loss eliminated the adverse metabolic oral contraceptive effects and led to higher ovulation rates.(54)”
Armstrong, A. A., Berger, M., & Al-Safi, Z. A. (2022) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000794 · Cited by 19
Samarasinghe, S., Oštarijaš, E., Long, M. J., Erridge, S., Purkayastha, S., Dimitriadis, G. K., & Miras, A. D. (2024) · Obesity Reviews · doi:10.1111/obr.13744 · Cited by 21
Treating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists
Goldberg, A. S., & Boots, C. E. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.05.154 · Cited by 24
The Search for the Causes of Common Hyperandrogenism, 1965 to Circa 2015
Rosenfield, R. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae007 · Cited by 19
Fu, W., & Kuang, Y. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1113840 · Cited by 16
Cutler, D. A., Shaw, A. K., Pride, S. M., Bedaiwy, M. A., & Cheung, A. P. (2018) · Trials · doi:10.1186/s13063-018-3009-5 · Cited by 15
Dashti, S., Hamid, H. A., Saini, S. M., Tusimin, M., Ismail, M., Esfehani, A. J., Ching, S. M., Lee, K. W., Ismail, N. B., Wong, J. L., et al. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01861-4 · Cited by 31
Hossain, M. A., Sharfaraz, A., Hasan, M. I., Somadder, P. D., Haque, M. A., Sarker, M. R., Alam, M. M., Hasan, A. M. W., Sohel, M. M. H., & Rahman, M. H. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.101073 · Cited by 13
McLean, S., & Boots, C. E. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777759 · Cited by 17
Malhotra, N., Arora, T., Suri, V., Jena, S. K., Verma, A., Gowri, M., Kapoor, N., Chalga, M. S., Kulkarni, B., & Kamath, M. S. (2023) · Trials · doi:10.1186/s13063-023-07466-y · Cited by 10
“Kapoor N, Sahay R, Kalra S, Bajaj S, Dasgupta A, Shrestha D, et al. Consensus on Medical Nutrition Therapy for Diabesity (CoMeND) in adults: a South Asian perspective.”
MethodInfluentialA Retrospective Study Examining Phentermine on Preconception Weight Loss and Pregnancy Outcomes
Chang, J., Lathi, R. B., & Kim, S. H. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0609 · Cited by 10
Xie, M., Yang, Y., & Zhang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1297841 · Cited by 13
Slocum, B., Shami, A. N., & Schon, S. B. (2022) · Women · doi:10.3390/women2020011 · Cited by 11
An update on pharmacotherapeutic strategies for obesity
Tchang, B. G., Tarazi, M. S., Aras, M., & Shukla, A. P. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1888927 · Cited by 12
Šuštaršič, A., Hadžić, V., Meulenberg, C. J. W., Abazović, E., Videmšek, M., Papler, T. B., & Paravlic, A. H. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1264947 · Cited by 20
Wang, M., Huang, J., Shi, Y., Mprah, R., Ding, H., Zhang, S., & Li, C. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108089 · Cited by 10
Wattar, B. H. A., Hussain, N., & Khan, K. S. (2022) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2021.10.010 · Cited by 13
Adeleye, A. J., Cruz, K., Cedars, M. I., Pasch, L. A., & Huddleston, H. G. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00673-y · Cited by 13
Vitek, W., Sun, F., Hoeger, K. M., Santoro, N. F., Diamond, M. P., Heping Zhang, D., Legro, R. S., Coutifaris, C., Christman, G. M., Robinson, R. D., et al. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.06.002 · Cited by 9
“The Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (OWL PCOS) trial randomized 216 women with obesity and PCOS to 16 weeks of continuous oral contraceptive pills, lifestyle modification or both followed by up to 4 cycles of ovulation induction with clomiphene (17).”
MethodSelf-citationKartchner, L., Dunn, A., Taylor, K. H., Ali, M. M., Manning, N., Dajani, N. K., & Magann, E. F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186582 · Cited by 16
“Similarly, one randomized controlled trial showed significant weight loss with an associated increase in ovulation rates in the lifestyle modification intervention group, but no significant effect on live birth rates [61].”
Navigating the Role of Anti-Obesity Agents Prior to Pregnancy: A Narrative Review
Goldberg, A. S., Dolatabadi, S., Dutton, H., & Benham, J. L. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1776795 · Cited by 9
Contemporary Management of Polycystic Ovarian Syndrome
ZIMMERMAN, L. D., SETTON, R., PEREIRA, N., & ROSENWAKS, Z. (2019) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000449 · Cited by 8
Holzer, I., Parry, J. P., Beitl, K., Pozderovic, B., Marculescu, R., & Ott, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092597 · Cited by 8
Phillips, J. K., & Higgins, S. T. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.07.023 · Cited by 9
The dual burden of obesity: decoding metabolism and female reproductive endocrinology
Chen, Y., Wang, R., Zhang, N., & Xu, L. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1627607 · Cited by 12
“…on the ovaries High cost; Gastrointestinal side effects (nausea, vomiting, diarrhea); requires injection (except oral semaglutide) Orlistat (Legro et al., 2015) Non-systemically acting weight-loss drug; improves ovulation rates in PCOS when combined with oral contraceptives Common side…”
Dokras, A., Coutifaris, C., Remaley, A. T., Mehta, N. N., Playford, M. P., Kunselman, A. R., Stetter, C. C., Dodson, W. C., & Legro, R. S. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004662 · Cited by 8
Self-citationde Loos, A. D., Jiskoot, G., Louwers, Y. V., Beerthuizen, A., Busschbach, J. J. V., & Laven, J. S. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020426 · Cited by 10
“However, Legro and colleagues did report on a preconception intervention (either 16 weeks of continuous oral contraceptive pills, lifestyle modification by low caloric diet, or both, followed by ovulation induction) in which live birth rates did not significantly differ between the groups [29].”
BackgroundReduction in the Free Androgen Index in Overweight Women After Sixty Days of a Low Glycemic Diet
Zapała, B., Marszalec, P., Piwowar, M. W., Chmura, O., & Milewicz, T. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2201-8618 · Cited by 14
The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome
Chatzis, P., Τζιόμαλος, Κ., Pratilas, G. C., Makris, V., Sotiriadis, A., & Dinas, K. D. (2018) · Folia Medica · doi:10.2478/folmed-2018-0036 · Cited by 8
Chen, Z., & ZhaoWei, C. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15211 · Cited by 9
“Three studies reported the data of pregnancy rate.(18,22,25) The pregnancy rate in combination treatment group and control group was 64.”
BackgroundResultInfluentialHow effective are lifestyle interventions for overweight women trying to conceive?
Hiller, R. A. F., & Griesinger, G. (2023) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000874 · Cited by 7
Das polyzystische Ovarsyndrom als genderspezifischer kardiometabolischer Risikofaktor
van Baal, L., & Tan, S. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01529-7 · Cited by 8
Weight and Eating Concerns in Women’s Reproductive Health
McCuen‐Wurst, C., Culnan, E., Stewart, N. L., & Allison, K. C. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0828-0 · Cited by 9
Self-citationCooney, L. G., Sammel, M. D., Lee, I. T., Clapp, M. A., Goldsammler, M., Scott, E. L., Bjorkman, S. H., Fisher, B. T., & Dokras, A. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.01.033 · Cited by 7
Self-citationLiu, X., Chen, P., Wang, M., Zhao, W., Lei, J., Shi, J., Mao, Y., Zhang, C., Liang, X., & Huang, R. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06661-2 · Cited by 7
“Neverthe-less, the result of a randomized controlled research argued against this doing [35], and some late clinical studies were swinging from the previous assumption that weight loss interventions improve reproductive outcomes [12, 36].”
ResultFertility Issues in Polycystic Ovarian Disease
Rushing, J. S., & Santoro, N. F. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.004 · Cited by 7
A decade in female reproduction: an endocrine view of the past and into the future
Μacut, D., Milutinović, D. V., Rašić-Marković, A., Brkljačić, J. M., Bjekić-Macut, J., & Stanojlović, O. P. (2018) · HORMONES · doi:10.1007/s42000-018-0073-x · Cited by 7
Waldman, I. N., & Legro, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813209-8.00026-1 · Cited by 11
Self-citationDetection of Pcos/Pcod and Prediction of Infertility at the Early Stage Based on RF-ELM Technique
Venkatachalam, C., & Rani, V. (2024) · Asian Conference on Intelligent Technologies (ACOIT) · doi:10.1109/acoit62457.2024.10941285 · Cited by 5
“One typical indication of obesity is elevated blood insulin levels, because of this, the ovaries produce more androgens [15].”
Yang, H., Xiao, Y.-Q., Liu, J., Xu, G., Li, J., Xiao, Z.-Y., Zhou, J., Zheng, X., Liu, L.-Y., Yu, Z., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-059090 · Cited by 7
Noguera-Navarro, C., Candela‐González, J., & Orenes‐Piñero, E. (2025) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001330 · Cited by 7
Endometrial Receptivity in Patients with Polycystic Ovary Syndrome
Albu, A. I., & Albu, D. N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98624 · Cited by 5
Contemporary Management of the Patient with Polycystic Ovary Syndrome
Francone, N. O., Ramirez, T., & Boots, C. E. (2023) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2023.08.003 · Cited by 7
Cutler, D. A. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0378929 · Cited by 6
“contrast, evidence suggests that lifestyle (diet, activity and stress management) influences ovulation and the effectiveness of fertility treatments (302-304).”
BackgroundResultImpact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
Dzienny, A. C., & Seifer, D. B. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15110518 · Cited by 7
Bolek, T., Turňová, P., Jánošová, S., Péč, M. J., Ságová, I., Nagy, N., Jurica, J., Mokáň, M., & Samoš, M. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.102885 · Cited by 7
Chen, Z., Tan, J., Wang, H., Zheng, B., Liu, J., Hao, G., Guo, Z., Sun, Z., & Yu, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.813188 · Cited by 6
“In contrast, another study demonstrated that no improvement in pregnancy outcomes could be verified after the implementation of COC pretreatment (10).”
ResultPharmacological Management of Obesity in Patients with Polycystic Ovary Syndrome
Kourtidou, C., & Τζιόμαλος, Κ. (2023) · Biomedicines · doi:10.3390/biomedicines11020496 · Cited by 7
Zhao, H., & Guo, Y. (2024) · Gynecologic and Obstetric Investigation · doi:10.1159/000539039 · Cited by 4
Pregnancy outcome in PCOS patients: The effects of letrozol combined with exercise
Manteghi, G., Shahraki, Z., Moghadam, M. N., & Ghanbarpour, M. H. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00142-z · Cited by 5
Living Your Best Life: Lifestyle Medicine for All Women
McHugh, J., Alexander, M., Kudesia, R., Krant, J., Comander, A. H., Tollefson, M., & Geyer, C. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221087677 · Cited by 7
“lifestyle evaluation can result in a significantly higher ovulation and live birth rate than oral contraceptive pills, and even that delaying pregnancy to improve preconception lifestyle can result in the same for obese women with PCOS, when compared to proceeding straight to treatment.(15,16) As such, PCOS offers a c…”
ResultPark, M.-J., Kim, E., Ok, J.-M., Choi, K.-H., & Lim, Y.-W. (2022) · Journal of Korean Medicine for Obesity Research · doi:10.15429/jkomor.2022.22.2.136 · Cited by 6
Eickman, K., Maxwell, R. A., McGinnis, L. K., Stanczyk, F. Z., Legro, R. S., & Lindheim, S. R. (2024) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdad176 · Cited by 6
Self-citationNazare, J., Balkau, B., & Borel, A. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_3 · Cited by 3
Effects of Exercise Intervention on the Improvement of Polycystic Ovary Syndrome
Wang, S., Zhang, Z., & Liu, Y. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88896 · Cited by 4
“[29] designed a randomized controlled trial, which 149 overweight/obese infertile PCOS women were pretreated with lifestyle, oral contraceptives or a combination of both for 16 weeks before entering the clomiphene ovulatory cycle to analyze the impact of lifestyle interventions on pregnancyassisted outcomes.”
MethodOvulation Induction With Gonadotropins
Delbaere, A., Bruyneel, A., & Papas, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65169-3 · Cited by 4
Impact of body weight on IVF: pathophysiology, outcomes, and clinical considerations
Sekula, N. M., Başar, M., & Pal, L. (2025) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000001023 · Cited by 2
“In patients with PCOS, weight loss does improve chances of naturally conceiving [101], though studies have not shown similar effects in those who subsequently use IVF.”
Polycystic Ovary Syndrome – Support and Prevention in Adolescence
Wechsung, K., Neumann, U., Balint, N., & Wiegand, S. (2025) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-2622-6321 · Cited by 5
“At this point, sonography of the ovaries to check for PCOM”
The relationship between overweight and female infertility
da Costa, M. M., Andrade, C. B., Soares, F. V. G., & Belfort, G. P. (2021) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v11i4.1167 · Cited by 2
Correlation between obesity and successful ovulation induction with Clomiphene citrate
Setiani, R. E., Dwiningsih, S. R., & Sari, G. M. (2022) · Qanun Medika - Medical Journal Faculty of Medicine Muhammadiyah Surabaya · doi:10.30651/jqm.v6i1.8309 · Cited by 2
Philippe, K., Teo, S. M., Perrotta, C., McAuliffe, F. M., & Phillips, C. M. (2024) · Obesity Reviews · doi:10.1111/obr.13822 · Cited by 4
“24,42 Some preconception interventions show promising results for the participating women in terms of weight loss, 65,66 but overall the evidence about preconception trials is limited 8 ; more research is thus required here.”
Healthy Moms, Healthy Babies: Culinary and Lifestyle Medicine for PCOS and Preconception Health
Thomas, O. W., & Kudesia, R. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276251327923 · Cited by 3
“40 Both lifestyle intervention groups had statistically signi fi cantly greater weight loss and higher ovulation rates than the OCPs alone group, while the OCPs alone approach also resulted in increased odds of metabolic syndrome.”
Considering minimal clinically important differences in assisted reproductive technology
Schwarze, J.-E., Broekmans, F. J., Gupta, S. K., Tennant, P. W. G., Sunkara, S. K., & D’Hooghe, T. (2025) · Fertility and Sterility · doi:10.1016/j.fertnstert.2025.06.026 · Cited by 3
Preconception health optimization in women with polycystic ovary syndrome − how to find the time?
Lennon, C., Voss, K. A., & Vitek, W. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000781 · Cited by 2
Lifestyle modifiable reproductive and metabolic disease in women
Teede, H. J., Joham, A. E., Harrison, C. L., & Boyle, J. A. (2016) · The Medical Journal of Australia · doi:10.5694/mja16.00891 · Cited by 2
Physical Exertion Immediately Before Early Preterm Delivery: A Case–Crossover Study
Chahal, H. S., Gelaye, B., Mostofsky, E., Sánchez, S. E., Mere, J. F., Mercado, F. G., Pacora, P., & Williams, M. A. (2019) · Epidemiology · doi:10.1097/ede.0000000000001008 · Cited by 2
Interpretation of clinical trial results: a committee opinion
Penzias, A., Bendikson, K. A., Butts, S., Falcone, T., Gitlin, S., Gracia, C. R., Hansen, K., Hill, M., Hurd, W. W., Jindal, S., et al. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.11.009 · Cited by 2
“Lifestyle modification including weight loss has also been evaluated with evidence of an increase in unassisted conception as well as conception following clomiphene (10, 11).”
BackgroundDasgupta, S., Mondal, J., Goswami, B., & Dasgupta, J. (2023) · Obstetrics & Gynecology Science · doi:10.5468/ogs.23142 · Cited by 4
“HA is a known inducer of hepatic lipase (HL), which promotes the catabolism of HDL, and an inhibitor of the lecithin-cholesterol acetyltransferase enzyme, which results in the conversion of VLDL remnants to HDL. Enhanced HL activity promotes the formation of small dense LDL [34,35].”
BackgroundAntiobesity drugs for obese women planning pregnancy
Li, R., Lam, K. S. L., & Ho, P. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817921-5.00030-8 · Cited by 3
Tulandi, T., & Weibel, H. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-52210-4_16 · Cited by 2
Is the Endometrium in Women with PCOS Compromised?
Piltonen, T. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108236263.022 · Cited by 1
Teratogenic risks of treated and untreated maternal obesity
Jones, R. E., & Zera, C. (2025) · Seminars in Perinatology · doi:10.1016/j.semperi.2025.152081 · Cited by 2
A Review of Dietary Interventions for Polycystic Ovary Syndrome: Identifying the Optimal Approach
Raja, N. T., Raja, S., Raja, A. K., Bhatta, S. R. C., & Grand, E. (2025) · Fertility Science and Research · doi:10.25259/fsr_27_2025 · Cited by 2
Lee, I. T., Barnhart, K. T., Hwang, W.-T., Hinkle, S. N., Johnstone, E. B., Mills, J. L., Caniglia, E. C., Schisterman, E. F., Mendola, P., Ryan, G. L., et al. (2025) · Human Reproduction · doi:10.1093/humrep/deaf124 · Cited by 2
Zahra, M., Shah, M., Iqbal, F., Zubair, T., Habib, R., & Zulfiqar, F. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04626-6 · Cited by 3
“These improvements are clinically meaningful, as prior validation studies suggest that a 0.5–1.0 point increase in domain scores corresponds to a patient-perceived enhancement in daily functioning (Legro et al. 2015).”
Influential11-Oxygenated androgens in PCOS: impact of PCOS phenotypes and first-line interventions
Dokras, A., Kunselman, A. R., Stetter, C. M., McPhaul, M. J., Stanczyk, F. Z., & Legro, R. S. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag329 · Cited by 1
Self-citationSíndrome dos ovários policísticos: particularidades no manejo da infertilidade
Carvalho, B. A. (2019) · Femina · doi:10.61622/0100-7254479201905 · Cited by 19
Banerjee, I., Mooroogiah, K., Banerjee, I., & Yagnik, V. D. (2026) · Global Journal of Medical Pharmaceutical and Biomedical Update · doi:10.25259/gjmpbu_73_2026 · Cited by 3
Silva, I. S. T., Costa, A. L. M. L., Araújo, H. F. D. A., Soares, L. L., Ribeiro, M. J. A., Araújo, R. F. D. A., dos Santos, T. N. B., Leão, T. L. D. O., & Lopes, A. G. (2020) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e3909.2020 · Cited by 9
Obstructive Sleep Apnea: Another Condition to Screen for in Women with Infertility
Bui, L. M., Bazalakova, M. H., Antony, K. M., & Cooney, L. G. (2022) · Women · doi:10.3390/women2010006 · Cited by 1
Wild, R. A., Edwards, R. K., Zhao, Y. D., Kim, A. S., & Hansen, K. R. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.06.001 · Cited by 2
“Remodeling the spiral arteries on the maternal side of the placenta is an essential early step in the pathogenesis of hypertensive disorders during pregnancy (14).”
BackgroundChannon, S., Coulman, E., Cannings-John, R. L., Henley, J., Lau, M., Lugg-Widger, F. V., Strange, H., Davies, F., Sanders, J., Scherf, C., et al. (2023) · Health Technology Assessment · doi:10.3310/nkix8285 · Cited by 1
Contraceptives, exercise and diet — are all three needed in PCOS?
Yıldız, B. O. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.106 · Cited by 1
Ovulation Induction in Women with Polycystic Ovary Syndrome: What is the Optimal Option?
Oriji, V. K., & Nyengidiki, K. (2018) · InTech eBooks · doi:10.5772/intechopen.70812 · Cited by 1
“In many countries, lifestyle intervention is recommended as this has led to higher spontaneous ovulation rates and natural conception rates [20, 21].”
BackgroundIntegrated Strategies for Enhancement of Fertility in PCOS
Coghlan, E., & Hart, R. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-45534-1_21 · Cited by 2
Effect of orlistat on obese women with polycystic ovary syndrome
Jiang, Q., & Shi, Y. (2018) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000017 · Cited by 2
Medical interventions to improve outcomes in infertile obese women planning for pregnancy
Talaulikar, V. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817919-2.00016-4 · Cited by 2
Painter, R. C., Finken, M. J. J., & van Rijn, B. B. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.07.006 · Cited by 1
Mills, G., & Tulandi, T. (2022) · Springer eBooks · doi:10.1007/978-3-030-99596-6_16 · Cited by 1
Waldman, I. N., & Legro, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64880-8 · Cited by 2
Self-citation5 Infertility and assisted reproduction
Maclean, A. (2004) · Routledge eBooks · doi:10.4324/9781843148913-19 · Cited by 1
Exploring new frontiers in the management of polycystic ovary syndrome associated obesity
Dokras, A., & Norman, R. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.10.030 · Cited by 1
Self-citationPrävention und Gesundheitsförderung
(2023) · Elsevier eBooks · doi:10.1016/b978-3-437-23571-9.00009-2
Lifestyle intervention in obese infertile women
van Oers, A. M. (2017) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Fertility Treatment for Women with PCOS
Langdon, F., Pontré, J., & Hart, R. J. (2017) · InTech eBooks · doi:10.5772/intechopen.71188 · Cited by 2
Is It Good Practice/Ethical to Set a Max BMI Before IVF?
Doyle, J., Doyle, N., & DeCherney, A. H. (2018) · Springer eBooks · doi:10.1007/978-3-319-90823-6_11
Pfaff, D. H. (2018) · Springer eBooks · doi:10.1007/978-3-662-55972-7_38
Schwangerschaft und Geburt bei Adipositas
Stubert, J. (2019) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-0840-7822
“Adipositas 2019; 13: 65–70 69 [8] Legro RS, Dodson WC, Kris-Etherton PM et al.”
Veazie, S., Gilbert, J., Winchell, K. A., Paynter, R. A., & Guise, J. (2019)
Metadata
- Authors
- Legro, R. S., Dodson, W. C., Kris-Etherton, P. M., Kunselman, A. R., Stetter, C. M., Williams, N. I., Gnatuk, C. L., Estes, S. J., Fleming, J., Allison, K. C., Sarwer, D. B., Coutifaris, C., & Dokras, A.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Legro, Richard S.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-11
- Volume
- 100
- Issue
- 11
- Pages
- 4048-4058
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4702450
- OpenAlex
- W2142157239
- Cited by
- 242
- References
- 42
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 25 · 2023: 26 · 2022: 30 · 2021: 20 · 2020: 22 · 2019: 17 · 2018: 28 · 2017: 22 · 2016: 18
- FWCI
- 25.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Virginia
- Hologic
- National Institutes of Health (UL1TR000127, UL1TR002014)
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54-HD29834, R01HD029834, P50HD028934, R01HD056510)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, female infertility, preconception interventions, lifestyle modification, weight loss, ethinyl estradiol, clomiphene citrate, ovulation induction, live birth, metabolic syndrome, obesity, sibutramine, orlistat, physical activity, caloric restriction, meal replacement, pregnancy outcomes, ovulation
- MeSH terms
- Adult, Behavior Therapy, Birth Rate, Clomiphene, Combined Modality Therapy, Diet, Reducing, Drug Resistance, Female, Fertility Agents, Female, Humans, Infertility, Female, Life Style, Motor Activity, Obesity, Ovulation Induction, Pennsylvania, Polycystic Ovary Syndrome, Pregnancy, Body Mass Index, Prevalence, Preconception Care, Pregnancy Rate, Anti-Obesity Agents, Metabolic Syndrome, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.